Abstract:Nano-structured lipid carriers (NLCs) have been widely used for oral drug delivery due to their remarkable biocompatibility and biodegradability. In addition to formulation and particle size, particle surface properties are important for overcoming gastrointestinal (GI) barriers to oral drug delivery by lipid-based nanoparticles. In this study, we describe polyethylene glycol (PEG)-based mucus-penetrating NLCs and we report the effect of surface hydrophilic properties on their oral delivery across the GI mucus and intestinal epithelium cells in vivo and in vitro. The solvent evaporation method was used to prepare PEG-modified NLCs (pNLCs) with three different levels of polyethylene glycol (100) monostearate (S100) as the hydrophilic coating material. The stability and cytotoxicity of pNLCs, as well as their uptake by Caco-2 cells and transport across Caco-2 monolayers and mucus-secreting Caco-2/HT29 coculture monolayers, were investigated to confirm the optimal PEG level for oral delivery. In situ single-pass perfusion experiments, in vivo imaging and in vivo oral pharmacokinetic studies were also performed in rodents to evaluate the oral absorption of pNLCs with different hydrophilic surface properties. Our results showed that the hydration layer thickness of the pNLCs increased with the increasing S100 content. NLC containing 20% S100 (pNLC-20%) showed the highest uptake by Caco-2 cells and the most effective permeation through Caco-2/HT29 coculture monolayers compared with unmodified NLC, pNLC-40% and pNLC-80%. In addition, pNLC-20% was the most stable during the process of oral administration and uptake into the blood circulation, as judged by fluorescence resonance energy transfer (FRET). Moreover, in situ single-pass perfusion experiments, ligated intestinal loops tests, in vivo imaging and pharmacokinetics studies also demonstrated that pNLC-20% most rapidly penetrated the intestinal epithelium and had the highest AUC and C-max of all the NLCs. In conclusion, optimization of surface hydrophilic properties is essential for enhancing the absorption of drugs delivered by oral administration of lipid-based nanocarriers.

[Uptake of Monostearin Solid Lipid Nanoparticles by A549 Cells].

Determination of surface properties and cell uptake in vitro of stearic acid solid lipid nanoparticles

STEARIC ACID SOLID LIPID NANOPARTICLES SURFACE-MODIFIED WITH POLY (ETHYLENE GLYCOL): PREPARATION AND UPTAKE BY CELLS IN VITRO

Effect of Peg2000 on Drug Delivery Characterization from Solid Lipid Nanoparticles

Cell Uptake of Paclitaxel Solid Lipid Nanoparticles Modified by Cell-Penetrating Peptides in A549 Cells.

Preparation and Cytotoxicity of 2-Methoxyestradiol-loaded Solid Lipid Nanoparticles.

Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells

Improved Transport and Absorption Through Gastrointestinal Tract by PEGylated Solid Lipid Nanoparticles

The Effect of PEGylation of Mesoporous Silica Nanoparticles on Nonspecific Binding of Serum Proteins and Cellular Responses

[Influence of Particle Size and MePEG Molecular Weight on in Vitro Macrophage Uptake and in Vivo Long Circulating of Stealth Nanoparticles in Rats].

Increasing Cellular Uptake of Mesoporous Silica Nanoparticles in Human Embryonic Kidney Cell Line 293T Cells by Using Lipofectamine 2000

New Method To Determine The Effect Of Surface Pegylation On Cellular Uptake Efficiency Of Mesoporous Silica Nanoparticles With Aiegens

Serum Proteins Opsonization and Phagocytic Uptake of PEG-Modified PLGA Nanoparticles: Effect of Particle Size

Effects of surface hydrophilic properties of PEG-based mucus-penetrating nanostructured lipid carriers on oral drug delivery

Influence of Different PEG Contents on the Phagocytic Uptake and Plasma Protein Adsorption of Mpeg-Plga-mpeg Nanoparticles

Monitoring the Interaction Between Solid Lipid Nanoparticles and Alveolar Macrophages via the Label-Free Technique

In Situ Evading Of Phagocytic Uptake Of Stealth Solid Lipid Nanoparticles By Mouse Peritoneal Macrophages

Uptake of oleoyl-chitosan nanoparticles by A549 cells.

Influence of Polyethyleneglycol Modification on Phagocytic Uptake of Polymeric Nanoparticles Mediated by Immunoglobulin G and Complement Activation.

Investigating the Effect of Particle Size on Cellular Uptake by Aggregation-Caused Quenching Probe–Encapsulating Solid Lipid Nanoparticles, Inhaled

Effect of poly(ethylene glycol) stearate on the phase behavior of monocaprate/Tween80/water system and characterization of poly(ethylene glycol) stearate-modified solid lipid nanoparticles